Advanced search

Bone and joint diseases in inflammatory bowel disease

Martine De Vos (UGent) , Filip De Keyser (UGent) , Herman Mielants (UGent) , Claude Cuvelier (UGent) and Eric Veys (UGent)
Author
Organization
Abstract
The intestinal and articular systems are closely linked in inflammatory bowel disease. Clinical and immunological studies support an important aetio-pathogenetic link between intestinal and articular inflammation, There is increasing evidence for a negative link between bone mass density and intestinal inflammation. This paper will focus on the prevalence, aetio-pathogenesis and treatment of arthritis (peripheral, sacroiliitis and spondylitis) and osteoporosis in inflammatory bowel disease.
Keywords
ANKYLOSING-SPONDYLITIS, CROHNS-DISEASE, GUT INFLAMMATION, SERONEGATIVE SPONDYLARTHROPATHIES, ULCERATIVE-COLITIS, MINERAL DENSITY, REACTIVE ARTHRITIS, OSTEOPOROSIS, SULFASALAZINE, PLACEBO

Citation

Please use this url to cite or link to this publication:

Chicago
De Vos, Martine, Filip De Keyser, Herman Mielants, Claude Cuvelier, and Eric Veys. 1998. “Bone and Joint Diseases in Inflammatory Bowel Disease.” Alimentary Pharmacology & Therapeutics 12 (5): 397–404.
APA
De Vos, Martine, De Keyser, F., Mielants, H., Cuvelier, C., & Veys, E. (1998). Bone and joint diseases in inflammatory bowel disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 12(5), 397–404.
Vancouver
1.
De Vos M, De Keyser F, Mielants H, Cuvelier C, Veys E. Bone and joint diseases in inflammatory bowel disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 1998;12(5):397–404.
MLA
De Vos, Martine, Filip De Keyser, Herman Mielants, et al. “Bone and Joint Diseases in Inflammatory Bowel Disease.” ALIMENTARY PHARMACOLOGY & THERAPEUTICS 12.5 (1998): 397–404. Print.
@article{178372,
  abstract     = {The intestinal and articular systems are closely linked in inflammatory bowel disease. Clinical and immunological studies support an important aetio-pathogenetic link between intestinal and articular inflammation, There is increasing evidence for a negative link between bone mass density and intestinal inflammation. This paper will focus on the prevalence, aetio-pathogenesis and treatment of arthritis (peripheral, sacroiliitis and spondylitis) and osteoporosis in inflammatory bowel disease.},
  author       = {De Vos, Martine and De Keyser, Filip and Mielants, Herman and Cuvelier, Claude and Veys, Eric},
  issn         = {0269-2813},
  journal      = {ALIMENTARY PHARMACOLOGY \& THERAPEUTICS},
  keyword      = {ANKYLOSING-SPONDYLITIS,CROHNS-DISEASE,GUT INFLAMMATION,SERONEGATIVE SPONDYLARTHROPATHIES,ULCERATIVE-COLITIS,MINERAL DENSITY,REACTIVE ARTHRITIS,OSTEOPOROSIS,SULFASALAZINE,PLACEBO},
  language     = {eng},
  number       = {5},
  pages        = {397--404},
  title        = {Bone and joint diseases in inflammatory bowel disease},
  volume       = {12},
  year         = {1998},
}

Web of Science
Times cited: